Literature DB >> 31297534

Determinants of place of death for end-stage cancer patients: evidence from China.

Zhong Li1,2, Shan Jiang3, Chengzhong Xu4, Fangfang Lu4, Ruibo He1,2, Zijin Pan1,2, Pei Zhang4, Liang Zhang1,2.   

Abstract

OBJECTIVE: To determine factors influence place of death (POD) for end-stage cancer patients and investigate how the healthcare utilization mediates on the effect of socioeconomic status (SES) on POD.
DESIGN: A population-based, retrospective study from July 2015 to June 2017.
SETTING: Yichang, China. PARTICIPANTS: 894 end-stage cancer patients. MAIN OUTCOME MEASURE: POD.
RESULTS: Patients of hospital death experience more inpatient hospitalization services (IHS) and emergency department visits. Patients enrolled in the New Rural Cooperative Medical Scheme (OR = 7.60, P < 0.001) and Urban Employee Basic Medical Insurance (OR = 28.0, P < 0.001) have higher rates of hospital death than those in the Urban Resident-based Basic Medical Insurance. Living with spouse (OR = 1.72, P = 0.019) and receiving higher education (OR = 1.92, P = 0.004), increase the likelihood of hospital death by 72% and 92%, respectively. The probability of hospital death will increase by 14% and decrease by 4% per IHS and outpatient services occur, respectively. Outpatient services (Z = -2.28, P < 0.001), and IHS (Z = 2.17, P < 0.001) mediate 1.81% and 1.89%, respectively, of the effect of health insurance on POD. The overall effect of the mediators is non-statistically significant (Z = 0.09, P = 0.825).
CONCLUSION: POD is mainly driven by SES. The relationship between health insurance and POD is partly mediated by outpatient services and IHS, respectively. The results corroborated that hospital and home services should be coherently bridged. Furthermore, benefit packages for end-stage cancer patients could be redesigned.
© The Author(s) 2019. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  China; cancer; death; end of life care; mediation; socioeconomic status

Mesh:

Year:  2020        PMID: 31297534     DOI: 10.1093/intqhc/mzz064

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  5 in total

1.  Disparities in end-of-life care, expenditures, and place of death by health insurance among cancer patients in China: a population-based, retrospective study.

Authors:  Zhong Li; Peiyin Hung; Ruibo He; Xiaoming Tu; Xiaoming Li; Chengzhong Xu; Fangfang Lu; Pei Zhang; Liang Zhang
Journal:  BMC Public Health       Date:  2020-09-04       Impact factor: 3.295

2.  Effect of Social Participation on the Physical Functioning and Depression of Empty-Nest Elderly in China: Evidence from the China Health and Retirement Longitudinal Survey (CHARLS).

Authors:  Dai Su; Zhifang Chen; Jingjing Chang; Guangwen Gong; Dandan Guo; Min Tan; Yunfan Zhang; Yanchen Liu; Xinlan Chen; Xinlin Chen; Yingchun Chen
Journal:  Int J Environ Res Public Health       Date:  2020-12-16       Impact factor: 3.390

3.  Place of death and phenomenon of going home to die in Chinese adults: A prospective cohort study.

Authors:  Li Weng; Yizhen Hu; Zhijia Sun; Canqing Yu; Yu Guo; Pei Pei; Ling Yang; Yiping Chen; Huaidong Du; Yuanjie Pang; Yan Lu; Junshi Chen; Zhengming Chen; Bin Du; Jun Lv; Liming Li
Journal:  Lancet Reg Health West Pac       Date:  2021-11-09

4.  Trends and associated factors in place of death among individuals with cardiovascular disease in China, 2008-2020: A population-based study.

Authors:  Wei Wang; Yunning Liu; Pengpeng Ye; Jiangmei Liu; Peng Yin; Jinlei Qi; Jinling You; Lin Lin; Feixue Wang; Lijun Wang; Yong Huo; Maigeng Zhou
Journal:  Lancet Reg Health West Pac       Date:  2022-02-02

5.  The experiences of clinical nurses coping with patient death in the context of rising hospital deaths in China: a qualitative study.

Authors:  Jinxin Zhang; Yingjuan Cao; Mingzhu Su; Joyce Cheng; Nengliang Yao
Journal:  BMC Palliat Care       Date:  2022-09-22       Impact factor: 3.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.